MAPT and Alzheimer disease: The National Institute on Aging and Alzheimer’s Association have advanced a classification scheme for brain aging and Alzheimer’s disease biomarker research based on three continuous dimensions, termed beta-amyloid deposition (A), pathologic tau (T), and neurodegeneration (N) [7].